Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours. World Health Organization International Histological Classification of Tumours, 2nd ed. Berlin: Springer-Verlag, 1988.
Rosai J, Carcangiu ML, DeLellis RA. Tumors of the thyroid gland. In Rosai J, Sobin H, editors. Atlas of Tumor Pathology, 3rd Series, Fasc 5. Washington, DC: A. F. I. P, 1992.
Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19:545–576.
Pasieka L, Zedenius J, Auer G, et al. Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 1992; 112:1154–1160.
Nishida T, Nakao K, Hamaji M, Nakahara M, Tsujimoto M. Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer. 1996; 119:568–575.
Sciacchitano S, Paliotta DS, Nardi F, Sacchi A, Andreoli M, Pontecorvi A. PCR amplification and analysis of RAS oncogenes from thyroid cytologic smears. Diagn Mol Pathol 1994; 3:114–121.
Hara H, Fulton N, Yashiro T, Ito K, DeGroot LJ, Kaplan EL. N-Ras mutation: an independent prognostic factor for aggressiveness of papillary thyroid carcinoma. Surgery 1994; 116:1010–1016.
Fagin JA, Matsuo K, Karmaker A, Chen DL, Tang S-H, Koeffler HP. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 1993; 91:179–184.
Donghi R, Longoni A, Pilotti S, Michieli P, Delia Porta G, Pierotti MA. Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland. J Clin Invest 1993; 91:1753–1760.
Soares P, Cameselle-Teijeiro J, Sobrinho-Simoes M. Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology 1994; 24:205–210.
Pilotti S, Collini P, Del Bo R, Cattoretti G, Pierotti MA, Rilke F. A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol 1994; 18:1054–1064.
Mazzanti C, Zeiger MA, Costourous N, Umbricht C, Westra WH, Smith D, et al. Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 2004; 64:2898–2903.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Oertel, Y.C. (2006). Classification of Thyroid Malignancies. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Humana Press. https://doi.org/10.1007/978-1-59259-995-0_8
Download citation
DOI: https://doi.org/10.1007/978-1-59259-995-0_8
Publisher Name: Humana Press
Print ISBN: 978-1-58829-462-3
Online ISBN: 978-1-59259-995-0
eBook Packages: MedicineMedicine (R0)